CNTN5 and prostate carcinoma: Moreover, the mutations in CNTN5 were reported to contribute to the metastatic process of pancreatic cancer (36), HTR4 was found predominantly in only high-grade prostate cancer (37, 38), and the high expression of TEKT3 could be influenced by HBV integration events in liver cancer (39).